Search results for: artificial intelligence

Artificial intelligence in market access

AI technologies are becoming increasingly relevant in many fields, such as business and marketing an...

Read more
The impact of AI on drug pricing and reimbursement

Artificial intelligence is set to revolutionise the market access and healthcare landscape, but huma...

Read more
PMA Insights: Week 20 SPECIAL EDITION – ISPO...

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...

Read more
ISPOR US 2023: Plenary Session 2 – AI wants ...

Our experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel...

Read more
2025 Market Access Check-In: Evaluating the Impact...

2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...

Read more
25 Years of NICE: Reflections and Achievements

Celebrating its 25th anniversary, NICE hosted a conference looking back at its progress and ahead to...

Read more
Pricing and Market Access trends: 2025

Our review of the 2024 pricing and market access revealed key challenges facing the pharmaceutical i...

Read more
AI could transform diabetes management to improve ...

Article originally published 17th August 2022, updated 11th June 2024. Introduction Artificial intel...

Read more
Reflecting on the Pricing & Market Access tre...

Back in January this year, we summarised the key trends our market access experts believed would dom...

Read more
UK Agencies join with International HTA Partners f...

A cross-border alliance of health technology assessment (HTA) agencies has been announced by the Can...

Read more
Older

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch